Eris Lifesciences receives ANVISA approval for Ahmedabad Sterile Injectable facility Ruchika Sharma27 Aug 2025 3:17 PM ISTMumbai: Following the Anvisa approval of an oral dose manufacturing unit, Eris Lifesciences Limited, an Indian branded formulations...
Eris Lifesciences Slapped Rs 17 Crore GST Notice Over Novartis Zomelis Deal Farhat Nasim27 Aug 2025 10:00 AM ISTNew Delhi: Eris Lifesciences Limited has disclosed that it has received a show cause-cum-demand notice amounting to Rs16.84 crore from the Directorate...
Eris Lifesciences receives ANVISA approval at its Ahmedabad campus Ruchika Sharma25 Aug 2025 5:00 PM ISTMumbai: Eris Lifesciences Limited, an Indian branded formulations manufacturing company, has announced that a manufacturing unit in its Ahmedabad...
Eris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial Mandated Parthika Patel23 July 2025 7:41 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
NPPA fixes retail prices of 71 formulations including Empagliflozin, Metformin, Sitagliptin and Glimepiride Ruchika Sharma8 July 2025 5:45 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 71 formulations under Drugs (Prices Control) Order,...
Revise Phase IV Protocol for Gliclazide-Sitagliptin FDC with Scientific Justification: SEC Tells Eris Dr. Divya Colin4 Jun 2025 3:01 PM ISTNew Delhi: Reviewing the Phase IV clinical trial of Eris Lifesciences' Fixed Dose Combination (FDC) antidiabetic drug Gliclazide plus Sitagliptin, the...
Eris Lifesciences designates Gopal Agrawal, Nita Borkar in leadership roles Ruchika Sharma2 April 2025 1:16 PM ISTMumbai: Eris Lifesciences Limited, an Indian branded formulations manufacturing company, has designated Gopal Agrawal and Nita Borkar in...
Eris Lifesciences gets CDSCO Panel nod To Initiate Phase III CT of Esaxerenone Tablets Dr. Divya Colin30 March 2025 6:00 PM ISTNew Delhi: Based on the bioequivalence (BE) study of the new drug Esaxerenone Tablets 1.25, 2.5 and 5 mg, the Subject Expert Committee (SEC)...
Eris Lifesciences transfers 100% stake in 2 arms to Eris Therapeutics for Rs 861.9 crore Ruchika Sharma7 March 2025 2:30 PM ISTAhmedabad: Eris Lifesciences has announced that the Company has transferred 100 percent of its holdings in two wholly-owned subsidiaries to...
Eris Lifesciences ropes in Murari Ranganathan as President, Cardiometabolic Business Ruchika Sharma6 March 2025 12:21 PM ISTMumbai: Eris Lifesciences Limited, a Indian branded formulations manufacturing company, has appointed Murari Ranganathan as President,...
Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel Farhat Nasim4 Dec 2024 5:00 PM ISTNew Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi Kendras...
Submit Source Data of Phase III CT Report: CDSCO Panel Tells Eris Lifesciences on Metoprolol Succinate plus Dapagliflozin FDC Dr. Divya Colin11 May 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of fixed-dose combination (FDC) drug, Metoprolol Succinate sustained released 25mg/50mg plus...
